VICE PRESIDENT OF CLINICAL OPERATIONS
- With AZTherapies since 2012; responsible for overseeing, planning, executing, and monitoring all clinical operational activities and programs
- More than 25 years of experience in clinical research, managing and monitoring Phase 1-3 clinical trials
- Key contributor to successful FDA drug approvals for Cubicin® (daptomycin for injection) at Cubist Pharmaceuticals (now Merck)
- Contributor to FDA approval for Kalbitor® (ecallantide) at Dyax Corp (now Takeda)
- Previous experience as a quality control chemist at Genetics Institute (Now Pfizer)
- Project Management Professional (PMP) certification 2010
- Served 8 years in the United States Air Force
- B.S. in Biology from Salem State University